Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

T315I-mutated Bcr-Abl in chronic myeloid leukemia and imatinib: insights from a computational study.

T315I-mutated Bcr-Abl in chronic myeloid leukemia and imatinib: insights from a computational study. Mol Cancer Ther. 2005 Aug; 4(8):1167-74.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.